Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 291579011000036118 | lanreotide 30 mg modified release injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 291580011000036118 | lanreotide 30 mg modified release injection, 30 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lanreotide 30 mg modified release injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| lanreotide 30 mg modified release injection, vial | Is a | lanreotide | true | Inferred relationship | Some | ||
| lanreotide 30 mg modified release injection, vial | has intended active ingredient | lanreotide | true | Inferred relationship | Some | 1473721024 | |
| lanreotide 30 mg modified release injection, vial | has Australian BoSS | lanreotide | true | Inferred relationship | Some | 1473721024 | |
| lanreotide 30 mg modified release injection, vial | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| lanreotide 30 mg modified release injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1473721025 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Somatuline LA (lanreotide 30 mg) modified release injection, 30 mg vial | Is a | True | lanreotide 30 mg modified release injection, vial | Inferred relationship | Some | |
| inert substance diluent [1 x 2 mL ampoule] (&) lanreotide 30 mg modified release injection [1 x 30 mg vial], 1 pack (medicinal product pack) | has MPUU | True | lanreotide 30 mg modified release injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR